1. Home
  2. KMDA vs SY Comparison

KMDA vs SY Comparison

Compare KMDA & SY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • KMDA
  • SY
  • Stock Information
  • Founded
  • KMDA 1990
  • SY 2013
  • Country
  • KMDA Israel
  • SY China
  • Employees
  • KMDA N/A
  • SY N/A
  • Industry
  • KMDA Biotechnology: Pharmaceutical Preparations
  • SY EDP Services
  • Sector
  • KMDA Health Care
  • SY Technology
  • Exchange
  • KMDA Nasdaq
  • SY Nasdaq
  • Market Cap
  • KMDA 430.1M
  • SY 482.1M
  • IPO Year
  • KMDA N/A
  • SY 2019
  • Fundamental
  • Price
  • KMDA $7.35
  • SY $3.74
  • Analyst Decision
  • KMDA Strong Buy
  • SY Strong Buy
  • Analyst Count
  • KMDA 2
  • SY 1
  • Target Price
  • KMDA $13.00
  • SY $5.50
  • AVG Volume (30 Days)
  • KMDA 49.4K
  • SY 1.8M
  • Earning Date
  • KMDA 08-13-2025
  • SY 08-15-2025
  • Dividend Yield
  • KMDA 2.72%
  • SY 0.71%
  • EPS Growth
  • KMDA 27.97
  • SY N/A
  • EPS
  • KMDA 0.32
  • SY N/A
  • Revenue
  • KMDA $169,517,000.00
  • SY $199,226,349.00
  • Revenue This Year
  • KMDA $14.51
  • SY $9.77
  • Revenue Next Year
  • KMDA $9.31
  • SY $62.98
  • P/E Ratio
  • KMDA $22.26
  • SY N/A
  • Revenue Growth
  • KMDA 9.67
  • SY N/A
  • 52 Week Low
  • KMDA $5.17
  • SY $0.66
  • 52 Week High
  • KMDA $9.16
  • SY $6.28
  • Technical
  • Relative Strength Index (RSI)
  • KMDA 48.99
  • SY 41.71
  • Support Level
  • KMDA $7.15
  • SY $4.53
  • Resistance Level
  • KMDA $7.85
  • SY $5.35
  • Average True Range (ATR)
  • KMDA 0.22
  • SY 0.51
  • MACD
  • KMDA 0.00
  • SY -0.18
  • Stochastic Oscillator
  • KMDA 54.13
  • SY 4.17

About KMDA Kamada Ltd.

Kamada Ltd is a drug-focused, plasma-derived protein therapeutics company. It is involved in the business of developing, producing, and marketing specialty therapeutics using protein purification proprietary technology. Its product portfolio consists of Glassia, Bramitob, Foster, Ixiaro, Factor-IX, and others. The company has two segments namely, the Proprietary Products segment and the Distribution segment. It derives the majority of its revenue from the Proprietary products segment. The firm categorizes its products in Lung Disease, Vaccines, Haemophilia, Immunoglobulins, Critical care, and Diagnostics.

About SY So-Young International Inc. American Depository Shares

So-Young International Inc is an online destination for discovering, evaluating, and reserving medical aesthetic services in China. Its business model comprises four integrated components: professional content and its distribution through social media networks and its targeted media platforms in China, a social community characterized by signature user-generated content, Online reservation services for a medical aesthetic treatment, and the research, development, production, sales and agency of laser and other optoelectronic medical beauty equipment. It generates revenue from information services fees and reservation services fees from medical aesthetic service providers.

Share on Social Networks: